CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Sustained glycemic control and less hypoglycemia with new insulin glargine 300 U/mL vs. 100 U/mL: 1-year results in T2DM with basal+mealtime insulin (EDITION 1)
DOI 10.1055/s-0035-1549543
Bibliografische Angaben
Nachweis in CareLit
Autor:innenR Ritzel, H Yki-Järvinen, GB Bolli, S Cissokho, PD Home, MC Riddle
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background and aims: EDITION 1 studied the efficacy and safety of new insulin glargine 300 U/mL (Gla-300) versus glargine 100 U/mL (Gla-100) in people with T2DM using basal plus mealtime insulin. Materials and methods: In EDITION 1, people (N = 807) with elevated HbA1c were randomized to titrate Gla-300 or Gla-100 once daily in the evening for 6 months while continuing mealtime insulin. In a 6-month open-label exten…
Zitieren
Zitierempfehlung
R Ritzel, H Yki-Järvinen, GB Bolli, S Cissokho, PD Home, MC Riddle (2015) Sustained glycemic control and less hypoglycemia with new insulin glargine 300 U/mL vs. 100 U/mL: 1-year results in T2DM with basal+mealtime insulin (EDITION 1). Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0035-1549543
Mit CareLit weiterarbeiten